Cannara Biotech (STU:8CB0) Capex-to-Operating-Income : 0.25 (As of Feb. 2025)

Cannara Biotech Capex-to-Operating-Income Chart

Cannara Biotech Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Capex-to-Operating-Income	Get a 7-Day Free Trial															-	2.04	0.10	0.29	0.25

Competitive Comparison of Cannara Biotech's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's Capex-to-Operating-Income falls into.

Cannara Biotech Capex-to-Operating-Income Calculation

Cannara Biotech's Capex-to-Operating-Income for the fiscal year that ended in Aug. 2024 is calculated as

Cannara Biotech's Capex-to-Operating-Income for the quarter that ended in Feb. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannara Biotech  (STU:8CB0) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Cannara Biotech Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech Business Description